These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10509924)

  • 1. Synthesis of piperazine derivatives and evaluation of their antihistamine and antibradykinin effects.
    Choo HY; Chung BJ; Chung SH
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2727-30. PubMed ID: 10509924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of [beta-(Aroylamino)ethyl]piperazines and -piperidines and [2-[(Arylamino)carbonyl]ethyl]piperazines, -pyrazinopyridoindoles, and -pyrazinoisoquinolines. A new class of potent H1 antagonists.
    Saxena M; Agarwal SK; Patnaik GK; Saxena AK
    J Med Chem; 1990 Nov; 33(11):2970-6. PubMed ID: 1977909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
    Frymarkiewicz A; Walczyński K
    Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antihistamines: substituted piperazine and piperidine derivatives as novel H1-antagonists.
    Abou-Gharbia M; Moyer JA; Nielsen ST; Webb M; Patel U
    J Med Chem; 1995 Sep; 38(20):4026-32. PubMed ID: 7562938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D QSAR studies on new piperazine derivatives with antihistamine and antibradykinin effects.
    Choo HY; Chung BJ
    Arch Pharm Res; 2000 Aug; 23(4):324-8. PubMed ID: 10976577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
    Iemura R; Kawashima T; Fukuda T; Ito K; Tsukamoto G
    J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
    Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 1,2,3-triazoles. 13. (Piperazinylalkoxy) [1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H1-antihistamine and mast cell stabilizing properties.
    Buckle DR; Rockell CJ; Smith H; Spicer BA
    J Med Chem; 1986 Nov; 29(11):2262-7. PubMed ID: 2431143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphoteric drugs. I. Synthesis and antiallergic activity of [4-(diphenylmethoxy)piperidino]-, [4-(diphenylmethyl)piperazinyl]- and [4-(diphenylmethylene)piperidino]alkanoic acid derivatives.
    Iwasaki N; Sakaguchi J; Ohashi T; Takahara E; Ogawa N; Yasuda S; Koshinaka E; Kato H; Ito Y; Sawanishi H
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2276-84. PubMed ID: 7859328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,6-Dialkylpiperazines. V. Synthesis of 2,6-alkylpiperazine derivatives structurally related to cinnarazine.
    Cignarella G; Testa E
    J Med Chem; 1968 May; 11(3):612-5. PubMed ID: 4385347
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on piperazine compounds. VI. Antihistaminic and anticholinergic effects of 2-phenylpiperazine derivatives].
    Ikeda Y; Nitta Y; Hirano I; Noda K; Yamada K
    Yakugaku Zasshi; 1970 Nov; 90(11):1452-6. PubMed ID: 4395023
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-(2-pyridinyl)piperazine derivatives with antianaphylactic, antibronchospastic, and mast cell stabilizing activities.
    Catto A; Motta G; Tajana A; Cazzulani P; Nardi D; Leonardi A
    J Med Chem; 1987 Jan; 30(1):13-9. PubMed ID: 2879915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological activity of 5-substituted 2-(N,N-dialkylaminoethyl)amino- and 2-N-methylpiperazinyl-1,3,4-thiadiazoles.
    Lalezari I; Shafiee A; Badaly A; Salimi MM; Khoyi MA; Abtahi F; Zarrindast MR
    J Pharm Sci; 1975 Jul; 64(7):1250-2. PubMed ID: 239205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.
    Mandhane SN; Ayer UB; Midha AS; Rao CT; Rajamannar T
    Drugs R D; 2008; 9(2):93-112. PubMed ID: 18298128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antihistaminics on bradykinin action].
    Shvarts GIa
    Biull Eksp Biol Med; 1979 Oct; 88(10):419-21. PubMed ID: 40631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-benzylpiperazino derivatives of 3-nitro-4-hydroxycoumarin with H1 antihistamine and mast cell stabilizing properties.
    Buckle DR; Outred DJ; Smith H; Spicer BA
    J Med Chem; 1984 Nov; 27(11):1452-7. PubMed ID: 6208360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
    Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-inflammatory effects of new piperazine and ethanolamine derivatives of H(1)-antihistaminic drugs.
    Ahmadi A; Khalili M; Nafarie A; Yazdani A; Nahri-Niknafs B
    Mini Rev Med Chem; 2012 Oct; 12(12):1282-92. PubMed ID: 22876948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and histamine H1-receptor antagonistic activity of some novel 4-amino-2-(substituted)-5-(substituted) aryl-6-[(substituted aryl) amino] pyrimidines.
    Chhabria MT; Patel VT; Rajan KS; Brahmkshatriya PS
    Arzneimittelforschung; 2009; 59(5):243-7. PubMed ID: 19537525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators].
    Ohmori K; Ishii H; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):399-409. PubMed ID: 6138301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.